Skip to main content
Company record · Ottignies-Louvain-la-Neuve
Belgian companySituation normaleSociété à responsabilité limitée

Mountvector Bio

Enterprise number
1015.077.878
VAT number
BE1015077878
Incorporated on
14 October 2024
Members only
Health score
Latest financial year
2025
m07-f model
Size
Not published
Workforce not declared
Equity
€174.4K
Financial year 2025
Net result
-€25K
Financial year 2025

Profile

Official information from the CBE (FPS Economy).

Mountvector Bio is a Belgian company (Société à responsabilité limitée) whose registered office is established at 1348 Ottignies-Louvain-la-Neuve. Its main activity falls under “Fabrication de médicaments” (NACE 21201).

Legal form
Société à responsabilité limitée
Legal situation
Situation normale
Date of incorporation
14 October 2024
Main activity (NACE)
21201Fabrication de médicaments

An activity that is, on the face of it, not covered by anti-money-laundering law. Learn more

Secondary activities

1 additional NACE code declared.

Your risk analysis on this company

AML Company ran Mountvector Bio through your due diligence questionnaire. Here are the first findings.

  • What is the geographic exposure of the client and of its transactions?

    Belgium only· Registered office published in the register

  • What is the company's solvency and lifecycle status?

    Trading, no proceedings· Legal situation published in the register

The rest of the analysis

Sanctions screening, politically exposed persons, ultimate beneficial owners, source of funds: AML Company runs them, documents them and keeps the proof in your file.

Run the full analysis

Log in

This preview is not a due diligence measure: it pre-qualifies questions from public data. Identifying the client and its ultimate beneficial owners requires documents collected and verified.

Establishments

1 active establishment unit declared with the CBE.

Implantation
Ottignies-Louvain-la-Neuve

1 establishment · 2 municipalities

Registered office1 establishment
Registered office
Fond des Més 5
Map
Establishment2367.582.235
Avenue de l'Hôpital 11
4000 Liège
Map

Finances & financial health

Annual accounts filed with the Central Balance Sheet Office (CBSO, National Bank of Belgium) and an aggregate health score (Altman Z″ model, completed with qualitative factors).

Zone Altman
Grade
Computed on
Financial trend

Equity & result

EquityResult
Key figures by financial year
Financial yearEquityResult
2025€174,355-€24,992

Financial ratios

Solvency, liquidity and profitability, computed year by year from the filed annual accounts.

Solvency
96,6%
Financial year 2025

Equity / balance sheet total

Liquidity
29,77 x
Financial year 2025

Current assets / debts due within one year

Net margin
-

This year's filing does not carry the item the calculation needs.

Result for the year / turnover

Operating margin
-

This year's filing does not carry the item the calculation needs.

Operating result / turnover

Long-term debt
-

This year's filing does not carry the item the calculation needs.

Debts due after one year / balance sheet total

Return on equity
-14,3%
Financial year 2025

Result for the year / equity

Ratios computed by AML Company from the items filed in the balance sheet and the income statement. They are not filed figures as such: the underlying amounts appear in the key figures above.

Filing history (1)
Financial yearFilingFiling typeModelSource
14/10/202431/12/202528/08/2026Initialm07-fBNB

Source: CBSO (NBB) filings, Belgian chart-of-accounts headings 9904 (result), 10/15 (equity), 9900 (gross margin), 9087 (workforce in FTE). Data available for filings from 2022 onwards.

Health score and detailed factors

The grade, the score out of 100, the Altman Z″ zone and the list of public alerts are for members only.

Unlock

Notices in the Belgian Official Gazette

Official acts and notices: incorporation, changes to the articles, appointments, dissolutions.

Source: Belgian Official Gazette (FPS Justice). The links open the official PDFs.

Frequently asked questions about Mountvector Bio

Quick answers on Mountvector Bio's identity, contact details and official CBE information.

What is Mountvector Bio's enterprise number (CBE)?
Mountvector Bio's official enterprise number with the Crossroads Bank for Enterprises (CBE) is 1015077878. This unique number identifies the company with every Belgian administration.
What is Mountvector Bio's VAT number?
Mountvector Bio's intra-Community VAT number is BE1015077878. It is the CBE number prefixed with “BE” and enables trade within the European Union.
Where is Mountvector Bio's registered office?
Mountvector Bio's registered office is located at Fond des Més 5, 1348 Ottignies-Louvain-la-Neuve, Belgium. This address is the official one declared with the CBE.
What is Mountvector Bio's legal form?
Mountvector Bio is incorporated under the legal form “Société à responsabilité limitée”. This form determines its legal and tax regime and its publication duties towards the Belgian Official Gazette.
When was Mountvector Bio incorporated?
Mountvector Bio was entered in the Crossroads Bank for Enterprises on 14 October 2024. This date is the official start of activity declared with the CBE.
Is Mountvector Bio still active?
Yes, Mountvector Bio is currently listed as an active company with the Crossroads Bank for Enterprises (CBE).
What is Mountvector Bio's main activity?
Mountvector Bio's declared main activity is: Fabrication de médicaments (NACE code 21201). This NACE code officially classifies the company in the European nomenclature of economic activities.
How many establishments does Mountvector Bio have?
Mountvector Bio declares 1 establishment unit registered with the CBE, on top of its registered office.
Has Mountvector Bio filed its annual accounts?
Yes. Mountvector Bio's latest annual accounts were filed with the Central Balance Sheet Office (CBSO, National Bank of Belgium) on 28 August 2026, for the financial year ended 31 December 2025. The filings can be consulted publicly with the NBB.
Which official notices concern Mountvector Bio?
2 official notices about Mountvector Bio are available in the Belgian Official Gazette: incorporation, changes to the articles, appointments, dissolutions. Every one of these acts is listed on this page with a link to the official PDF.
Is Mountvector Bio subject to anti-money-laundering obligations in Belgium?
On the face of it, no. Mountvector Bio's declared activity is not among the professions expressly covered by the Act of 18 September 2017. This general information is not legal advice.

Company timeline

Every dated event in the company's life, from filed accounts to notices published in the Belgian Official Gazette, in a single thread.

Timeline
3 events
Filter the timeline by event type

10 AI-analysed dimensions are not shown.

  1. 2026
    1. 28 August 2026Annual accounts filed·Financial year ended 31 December 2025 · Model m07-fFiled accounts2026-00441422
  2. 2025
    1. 26 August 2025Registered office · Other addressView the notice25108211
  3. 2024
    1. 16 October 2024IncorporationView the notice24436887

Registry record since 7 September 2026

The KBO publishes its changes as a monthly delta and never restates the past: our record starts on that date, not at the company's incorporation. No change recorded since that date. A missing row says nothing about the company, only about how far back our record goes.

AI insights · Pro AI plan

AI extraction of strategic AML data

The official notices in the Belgian Official Gazette are analysed by our AI engine to extract automatically the information that matters for your due diligence and your AML duties.

  • Legal life
  • Restructuring
  • Capital
  • Legal form
  • Incorporation
  • Directors
  • Beneficial owners
  • Registered office
  • Company name
  • Notarial deeds
AML Company

Step it up
Full analysis unlocked.

Create an account to unlock the detailed analysis: health score, full history, alerts and PDF exports.

    We respect your privacy

    We use cookies that are essential to running the site and, with your consent, anonymised audience-measurement cookies (hosted in the EU) to improve our services. Learn more.